BRUGNOLI, Federica
 Distribuzione geografica
Continente #
NA - Nord America 2.969
EU - Europa 1.062
AS - Asia 662
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.694
Nazione #
US - Stati Uniti d'America 2.955
IT - Italia 407
CN - Cina 274
PL - Polonia 242
SG - Singapore 224
UA - Ucraina 136
DE - Germania 102
TR - Turchia 88
GB - Regno Unito 69
ID - Indonesia 53
FI - Finlandia 34
SE - Svezia 28
BE - Belgio 14
CA - Canada 14
FR - Francia 13
VN - Vietnam 13
LT - Lituania 9
AT - Austria 4
IN - India 4
IR - Iran 4
NL - Olanda 2
AE - Emirati Arabi Uniti 1
CH - Svizzera 1
EU - Europa 1
GR - Grecia 1
KR - Corea 1
Totale 4.694
Città #
Fairfield 391
Woodbridge 359
Ferrara 262
Warsaw 242
Ann Arbor 206
Chandler 206
Houston 203
Singapore 177
Ashburn 164
Seattle 158
Jacksonville 151
Cambridge 147
Santa Clara 141
Wilmington 129
Izmir 66
Beijing 64
New York 57
Princeton 57
Jakarta 53
Nanjing 52
Shanghai 39
San Diego 33
Addison 25
Boardman 24
Munich 20
Nanchang 18
Bologna 16
Bremen 15
Los Angeles 15
Auburn Hills 14
Brussels 13
Shenyang 13
Dearborn 12
Dong Ket 12
Milan 12
Rimini 12
Falls Church 11
Tianjin 10
Mountain View 8
Norwalk 8
Toronto 8
Catania 7
Changsha 7
Jinan 7
Ariano nel Polesine 6
Chicago 6
Leawood 6
London 6
Guangzhou 5
Hebei 5
Jiaxing 5
Kunming 5
Redwood City 5
San Mateo 5
Zhengzhou 5
Augusta 4
Haikou 4
Montréal 4
Philadelphia 4
Treviso 4
Verona 4
Vienna 4
Washington 4
Changchun 3
Frankfurt am Main 3
Hangzhou 3
Helsinki 3
Hounslow 3
Modena 3
Monmouth Junction 3
San Francisco 3
Taizhou 3
Ardabil 2
Arezzo 2
Des Moines 2
Ferrara di Monte Baldo 2
Hefei 2
Kilburn 2
Lappeenranta 2
Ningbo 2
Orange 2
Ottawa 2
Ozzano dell'Emilia 2
Pegola 2
Redmond 2
San Mauro Pascoli 2
Tappahannock 2
Trieste 2
Venice 2
Yellow Springs 2
Acton 1
Amsterdam 1
Bangalore 1
Bentivoglio 1
Bonate Sopra 1
Chongqing 1
Clearwater 1
Cremenaga 1
Delhi 1
Edinburgh 1
Totale 3.808
Nome #
Phospholipase C-beta2 promotes mitosis and migration of human breast cancer-derived cells 166
A network including PU.1, Vav1 and miR-142-3p sustains ATRA-induced differentiation of acute promyelocytic leukemia cells - a short report 165
In triple negative breast tumor cells, PLC-beta 2 promotes the conversion of CD133(high) to CD133(low) phenotype and reduces the CD133-related invasiveness 147
Vav1 is necessary for PU.1 mediated upmodulation of miR-29b in acute myeloid leukaemia-derived cells 142
null 134
Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit 130
Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a 129
Up-modulation of PLC-beta2 reduces the number and malignancy of triple-negative breast tumor cells with a CD133+/EpCAM+ phenotype: A promising target for preventing progression of TNBC 128
High nuclear level of Vav1 is a positive prognostic factor in early invasive breast tumors: a role in modulating genes related to the efficiency of metastatic process 124
VAV PROMOTES DIFFERENTIATION OF HUMAN TUMORAL MYELOID PRECURSORS 123
Vav1 downmodulates Akt in different breast cancer subtypes: A new promising chance to improve breast cancer outcome 116
Mass spectrometry-based identification of Y745 of Vav1 as a tyrosine residue crucial in maturation of acute promyelocytic leukemia-derived cells 116
Vav1 is a crucial molecule in monocytic/macrophagic differentiation of myeloid leukemia-derived cells 115
Protective role of all-trans retinoic acid (ATRA) against hypoxia-induced malignant potential of non-invasive breast tumor derived cells 115
CD133 in Breast Cancer Cells: More than a Stem Cell Marker 115
Ornithine decarboxylase, polyamines and CD11b expression in HL-60 cells during differentiation induced by retinoic acid. 115
Mitigation of tumor necrosis factor alpha cytotoxicity by aurintricarboxylic acid in human peripheral B lymphocytes 114
Association of PI 3-K with tyrosine phosphorylated Vav is essential for its activity in neutrophil-like maturation of myeloid cells 111
Nuclear proteome analysis reveals a role of Vav1 in modulating RNA processing during maturation of tumoral promyelocytes 110
Retinoic acid maintains differentiated cell morphology and functions in long-term cultured porcine hepatocytes: Obtaining functional cells for prolonged treatments with bioartificial liver 108
The role of the nuclear Akt activation and Akt inhibitors in all-trans-retinoic acid-differentiated HL-60 cells. 108
Vav1 and PU.1 are recruited to the CD11b promoter in APL-derived promyelocytes: Role of Vav1 in modulating PU.1-containing complexes during ATRA-induced differentiation 106
Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells 106
Vav1 in differentiation of tumoral promyelocytes 105
hnRNP K in PU.1-containing complexes recruited at theCD11bpromoter: a distinct role in modulating granulocytic and monocytic differentiation of AML-derived cells 102
Vav1 modulates protein expression during ATRA-induced maturation of APL-derived promyelocytes: a proteomic-based analysis. 102
PLCB2 (phospholipase C, beta 2). 98
PLC-β2 is highly expressed in breast cancer and is associated with a poor outcome: A study on tissue microarrays 97
PLC-beta2 monitors the drug-induced release of differentiation blockade in tumoral myeloid precursors 86
RNA interference in the study of molecular mechanisms activated during agonist induced differentiation of acute promyelocytic leukemia derived promyelocytes 81
Vav1: a key player in aginist-induced differentiation of promyelocytes from Acute Myeloid leukemia (APL). 68
Inositide-modifying enzymes: a cooperative role in regulating nuclear morphology during differentiation of myeloid cells. 66
Pulsed Electromagnetic Fields Modulate miRNAs During Osteogenic Differentiation of Bone Mesenchymal Stem Cells: a Possible Role in the Osteogenic-angiogenic Coupling 65
Nuclear inositide-metabolism in granulocytic differentiation of myeloid cells. 64
Ethanol-based garlic extract prevents malignant evolution of non-invasive breast tumor cells induced by moderate hypoxia 64
Requirement of tyrosine-phosphorylated Vav for morphological differentiation of all-trans-retinoic acid-treated HL-60 cells 63
Phosphoinositide 3-kinase is associated to the nucleus of HL-60 cells and is involved in their ATRA-induced granulocytic differentiation 58
Selective up-regulation of phospholipase C-beta 2 during granulocytic differentiation of normal and leukemic hematopoietic progenitors 56
Imidazo[1,2-b]pyrazole-7-carboxamide derivative induces differentiation-coupled apoptosis of immature myeloid cells such as acute myeloid leukemia and myeloid-derived suppressor cells 53
Integrative proteomic and functional analyses provide novel insights into the action of the repurposed drug candidate nitroxoline in AsPC-1 cells 51
UC.183, UC.110, and UC.84 ultra-conserved RNAs are mutually exclusive with mir-221 and are engaged in the cell cycle circuitry in breast cancer cell lines 48
The Molecular Networks of microRNAs and Their Targets in the Drug Resistance of Colon Carcinoma 46
null 45
Deregulated microRNAs in breast ductal carcinoma in situ (DCIS) with invasive propensity 41
Vav1 Down-Modulates Akt2 Expression in Cells from Pancreatic Ductal Adenocarcinoma: Nuclear Vav1 as a Potential Regulator of Akt Related Malignancy in Pancreatic Cancer 40
In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133high to CD133low phenotype and reduces the CD133-related invasiveness 39
Effects of garlic extract on breast tumor cells: a phenotype dependent modulation of morphology, cell cycle and invasive potential 38
A Multidisciplinary Approach Establishes a Link between Transglutaminase 2 and the Kv10.1 Voltage-Dependent K+ Channel in Breast Cancer 37
Vav1 Sustains the In Vitro Differentiation of Normal and Tumor Precursors to Insulin Producing Cells Induced by all-Trans Retinoic Acid (ATRA) 37
Targeting the Vav1/miR‐29b axis as a potential approach for treating selected molecular subtypes of triple‐negative breast cancer 34
The Motility and Mesenchymal Features of Breast Cancer Cells Correlate with the Levels and Intracellular Localization of Transglutaminase Type 2 32
ROLE OF VAV1 IN DIFFERENTIATION ALONG THE MONOCYTIC-MACROPHAGIC LINEAGE OF TUMORAL MYELOID PRECURSORS 30
Novel Insights into the Mechanism of Action and Modulation of Microvesicle Release by Nitroxoline in Pancreatic Cancer Cells Using Integrative Proteomic and Functional Analyses 28
EVALUATION OF DIFFERENT STORAGE CONDITIONS ON CHEMICAL COMPOSITION AND BIOACTIVE COMPOUNDS OF VOGHIERA GARLIC PDO 26
The Effect of Different Storage Conditions on Phytochemical Composition, Shelf-Life, and Bioactive Compounds of Voghiera Garlic PDO 25
Vav1 regulates phenotypic differentiation of AML-derived promyelocytes to monocytes/macrophages 23
PLC-β2 is modulated by low oxygen availability in breast tumor cells and plays a phenotype dependent role in their hypoxia-related malignant potential 22
PLC-beta2 activity on actin-associated polyphosphoinositides promotes migration of differentiating tumoral myeloid precursors. 18
THE MULTIDOMAIN PROTEIN VAV1 IN THE DIFFERENTIATION OF PLURIPOTENT STEM CELLS TO INSULIN-PRODUCING CELLS 17
Cell-Impermeable Inhibitors Confirm That Intracellular Human Transglutaminase 2 Is Responsible for the Transglutaminase-Associated Cancer Phenotype 16
Metabolic characterisation of transglutaminase 2 inhibitor effects in breast cancer cell lines 15
Mir-29b in Breast Cancer: A Promising Target for Therapeutic Approaches 14
Vav1 Selectively Down-Regulates Akt2 through miR-29b in Certain Breast Tumors with Triple Negative Phenotype 11
Chlorogenic acid permeation across intestinal cell monolayers: Influence by circadian rhythms in the presence of other natural polyphenols and by dopaminergic neuronal-like cells 10
Phenotype-dependent role of Vav1 in down-modulating Akt in invasive breast tumor cells 10
Metabolic fingerprinting of breast cancer cell lines: discovering similarities and differences 8
Totale 4.832
Categoria #
all - tutte 25.392
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 599
Totale 25.991


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020582 0 0 0 0 53 94 77 97 79 93 59 30
2020/2021862 46 45 49 59 161 88 71 94 26 107 65 51
2021/2022523 16 46 49 29 15 44 29 34 12 54 46 149
2022/2023536 52 33 29 59 74 54 26 73 62 2 42 30
2023/2024384 31 37 5 13 21 79 17 48 11 9 17 96
2024/2025507 46 50 146 77 188 0 0 0 0 0 0 0
Totale 4.832